22nd Century Group (XXII) Misses Q3 EPS by 6c, Revenues Beat

Go back to 22nd Century Group (XXII) Misses Q3 EPS by 6c, Revenues Beat

22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020

November 5, 2020 7:00 AM EST

Key Highlights:

22nd Century remains focused on its primary mission of reducing the harm caused by smoking. To this end, in recent weeks the Company has intensified its proactive efforts to secure a Modified Risk Tobacco Product (MRTP) authorization from the U.S. Food and Drug Administration (FDA) for VLN®. With 95% less nicotine than leading brands - or any other cigarette in the U.S. - VLN® will make 22nd Century the first, and only company in... More